American Botanical Council Submits Comments to FDA Suggesting Rescheduling of Cannabis
ABC highlights clinical research supporting therapeutic benefits, noting that current Schedule I drug status significantly impedes research efforts on cannabis, cannabis preparations, and its compounds. AUSTIN, Texas (April 26, 2018) — The nonprofit American Botanical...
Warning and Recommendation from CDC on Contaminated Synthetic Cannabinoids
Node Smith, ND The CDC has issued a warning and recommendations for clinicians regarding a multi-state outbreak of coagulopathy linked to the use of synthetic cannabinoids.1 The first case of coagulopathy due to synthetic cannabinoid use was reported in March 2018,...Cyrex Laboratories Launches Breakthrough Wheat/Gluten Test
PHOENIX, June 19, 2018 (GLOBE NEWSWIRE) — Cyrex Laboratories, a clinical laboratory specializing in environmental triggers and autoimmunity, is pleased to introduce the next step forward in wheat/gluten reactivity testing with its Array 3X, Wheat/Gluten Proteome...
